Serotonin levels are conclusively linked to clinical depression
The direct, definitive link between serotonin levels and clinical depression is heavily contested in modern psychiatric research, with accumulating evidence pointing to a complex interplay of inflammation, neuroendocrine regulation, and multiple neurotransmitter systems.
While classical literature and genetic studies (e.g., papers 0, 6, and 8) continue to explore serotonergic mechanisms and polymorphisms in mood disorders, contemporary clinical reviews and biomarker studies (e.g., papers 2, 3, and 7) emphasize that depression is multifactorial—strongly driven by inflammation, glutamatergic pathways, and multi-system neurobiology—thereby challenging the notion that serotonin levels are conclusively or solely linked to clinical depression.
Vladimir M. Kovalzon. Serotonin, Sleep and Depression: A Hypothesis. 2022. https://doi.org/10.5772/intechopen.96525
Paper [0] affirms that the monoamine deficiency hypothesis, specifically involving serotonin, remains a primary explanation for endogenous depression.
Hajivalizadeh S, Farahmand K, Kazemzadeh K, Hajivalizadeh G, Shamabadi A. Pharmacotherapeutic Management of Depression in Patients With Cancer: A Review of Mechanistic and Clinical Evidence.. 2026. https://doi.org/10.1002/cnr2.70587
Paper [2] highlights that conventional selective serotonin reuptake inhibitors often yield conflicting results, pointing to alternative mechanisms like inflammation and glutamate excitotoxicity.
See more details
Blambila L, Sabei P, Raulino VG, Herkenhoff ME. Pharmacogenetics of antidepressant response: a focused review on CYP2C19, CYP2D6, SLC6A4, and HTR2A polymorphisms.. 2026. https://doi.org/10.3389/fphar.2026.1773677
Paper [6] notes that functional variants in serotonergic genes like SLC6A4 modulate serotonin transporter availability and influence antidepressant responses.
Bocharov AV, Savostyanov AN, Tamozhnikov SS, Saprygin AE, Lebedkin DA, Merkulova EA, Knyazev GG. Features of connectivity of default mode network depending on polymorphism of serotonin transporter gene (5-HTTLPR).. 2026. https://doi.org/10.18699/vjgb-26-30
Paper [8] discusses how serotonin transporter gene polymorphisms affect brain connectivity networks associated with mood regulation and emotional processing.
Hummad H, Gairola P, Matakhov D, Shah S, Jeyakkodi H, Rahming N, Eze C, Yassa M, Armbrister US, Drum Christie SS, Rizwanullah U. The Role of Inflammatory Markers as Predictors of Response to Antidepressants in Major Depressive Disorder: A Meta-Analysis.. 2026. https://doi.org/10.7759/cureus.107728
Paper [3] demonstrates that elevated inflammatory markers predict antidepressant nonresponse, emphasizing non-serotonergic pathways in major depressive disorder.
Chen G, Tang X, Chen P, Chen R, Chen C, Zhang Y, Wang Z, Li F, Fei J, Lu D, Wang X, Xiao X, Wang Y, Huang X. Intrinsic regional brain activity differences and its relationship with neurotransmitter and gene expression in postpartum depression: a voxel-based meta-analysis.. 2026. https://doi.org/10.1017/s0033291726103651
Paper [7] shows that functional brain alterations in depression overlap with multiple neurotransmitter and genetic systems beyond just serotonin.
The paper trail · every fact has a biography
Challenge the receipt
Citation formatting by citeproc-js (Frank Bennett) and the Citation Style Language project. Source and licenses.
Terms · Privacy · How verdicts work · Dispute this receipt